Lipigon Pharmaceuticals AB (publ)

    Lipigon Pharmaceuticals AB (publ)

    SSTO:LPGO
    - -
    SEK
    - -
    - -
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    0.11
    0.26
    0.2
    - -
    0.2
    0.07
    - -
    - -
    Basic EPS, GAAP
    -0.23
    -0.31
    -0.49
    -2.57
    -1.63
    -0.15
    -0.18
    -0.08
    -0.07
    Free Cash Flow per Basic Share
    -0.2
    -0.34
    -0.53
    -2.22
    -1.62
    -0.17
    -0.18
    -0.09
    -0.08
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.27
    -0.36
    -1.34
    -3.9
    -4.27
    -1.19
    -0.89
    -0.39
    -0.36
    Tangible Book Value per Share
    -0.05
    0.13
    0.8
    1.44
    0.17
    0.34
    0.06
    0.02
    0.02
    Basic Weighted Avg Shares
    16
    16
    16
    16
    23
    84
    138
    404
    440
    Sales/Revenue/Turnover
    - -
    2
    4
    3
    - -
    16
    10
    - -
    - -
    Operating Margin (%)
    -20,933.33
    -283.08
    -182.89
    -1,295.31
    - -
    -75.41
    -248.63
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -4
    -5
    -8
    -41
    -38
    -12
    -25
    -32
    -32
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -20,933.33
    -286.06
    -188.59
    -1,292.86
    - -
    -73.92
    -245.59
    - -
    - -
    Working Capital
    -1
    2
    13
    23
    4
    28
    8
    8
    8
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    -1
    2
    13
    23
    4
    28
    8
    8
    8
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    606
    606
    606
    Market Capitalization
    28
    57
    4

    Working Capital

    SEK

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    26
    18
    11
    Cash, Cash Equivalents & STI
    25
    17
    10
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    4
    3
    4
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    111.55%
    1.96%
    Free Cash Flow
    - -
    74.56%
    43.44%
    Net Income, GAAP
    - -
    94.03%
    28.4%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    16
    - -
    - -
    16
    2024
    - -
    9
    - -
    1
    10
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.26
    0.08
    -0.05
    -0.07
    -0.15
    2024
    -0.07
    - -
    -0.05
    -0.06
    -0.18
    2025
    -0.05
    -0.02
    -0.01
    - -
    -0.08

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business